| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2021-09-14 15:00:08 UTC |
|---|
| HMDB ID | HMDB0000350 |
|---|
| Secondary Accession Numbers | - HMDB0002534
- HMDB00350
- HMDB02534
|
|---|
| Metabolite Identification |
|---|
| Common Name | 3-Hydroxysebacic acid |
|---|
| Description | 3-Hydroxydecanedioic is a dicarboxylic acid that belongs to the class of compounds known hydroxy fatty acids. Hydroxy fatty acids are fatty acids that have hydroxyl functional groups attached to the principal chain. 3-Hydroxydecanedioic acid is found in most vertebrates. Urine from patients with ketoacidosis typically contains a number of aliphatic 3-hydroxy dicarboxylic acids, with the major compound being 3-hydroxydecanedioic acid (PMID: 7353273 ). The excretion of 3-hydroxydecanedioic acid is correlated with the excretion of hexanedioic acid, another metabolite frequently found in ketoacidosis (PMID: 5031780 ). It is thought that the 3-hydroxy dicarboxylic acids such as 3-hydroxydecanedioic acid are formed from fatty acids by a combination of omega-oxidation and incomplete beta-oxidation (PMID: 7353273 ). Marked elevation of urinary 3-hydroxydecanedioic acid has also been reported in a malnourished infant with glycogen storage disease (PMID: 8295400 ). Subsequent studies have shown that increased amounts of dicarboxylic acids, such as 3-hydroxydecanedioic acid, are typically excreted in human urine under conditions of medium-chain triglyceride (MCT) feeding, abnormal fatty acid oxidation (FAO) and fasting (PMID: 8596483 ). |
|---|
| Structure | O[C@H](CCCCCCC(O)=O)CC(O)=O InChI=1S/C10H18O5/c11-8(7-10(14)15)5-3-1-2-4-6-9(12)13/h8,11H,1-7H2,(H,12,13)(H,14,15)/t8-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 3-Hydroxysebacate | Generator | | (R)-3-Hydroxydecanedioic acid | HMDB | | (R)-3-Hydroxysebacic acid | HMDB | | 3-Hydroxydecanedioic acid | HMDB | | 3-Hydroxy-decanedioic acid | HMDB | | 3-Hydroxy-sebacic acid | HMDB | | 3-Hydroxy-decanedioate | HMDB | | 3-Hydroxy-sebacate | HMDB | | 3-Hydroxydecanedioate | HMDB | | 3-Hydroxysebacic acid | HMDB |
|
|---|
| Chemical Formula | C10H18O5 |
|---|
| Average Molecular Weight | 218.249 |
|---|
| Monoisotopic Molecular Weight | 218.11542368 |
|---|
| IUPAC Name | (3R)-3-hydroxydecanedioic acid |
|---|
| Traditional Name | (3R)-3-hydroxydecanedioic acid |
|---|
| CAS Registry Number | 446881-43-2 |
|---|
| SMILES | O[C@H](CCCCCCC(O)=O)CC(O)=O |
|---|
| InChI Identifier | InChI=1S/C10H18O5/c11-8(7-10(14)15)5-3-1-2-4-6-9(12)13/h8,11H,1-7H2,(H,12,13)(H,14,15)/t8-/m1/s1 |
|---|
| InChI Key | OQYZCCKCJQWHIE-MRVPVSSYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as medium-chain hydroxy acids and derivatives. These are hydroxy acids with a 6 to 12 carbon atoms long side chain. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Hydroxy acids and derivatives |
|---|
| Sub Class | Medium-chain hydroxy acids and derivatives |
|---|
| Direct Parent | Medium-chain hydroxy acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Medium-chain hydroxy acid
- Medium-chain fatty acid
- Hydroxy fatty acid
- Beta-hydroxy acid
- Fatty acyl
- Fatty acid
- Dicarboxylic acid or derivatives
- Secondary alcohol
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.37 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.9348 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.89 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 177.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1364.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 221.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 103.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 163.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 121.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 309.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 351.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 244.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 712.5 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 297.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1016.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 211.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 246.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 565.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 196.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 330.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 3-Hydroxysebacic acid,1TMS,isomer #1 | C[Si](C)(C)O[C@H](CCCCCCC(=O)O)CC(=O)O | 1906.2 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,1TMS,isomer #2 | C[Si](C)(C)OC(=O)CCCCCC[C@@H](O)CC(=O)O | 1915.3 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,1TMS,isomer #3 | C[Si](C)(C)OC(=O)C[C@H](O)CCCCCCC(=O)O | 1933.8 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCCCC[C@H](CC(=O)O)O[Si](C)(C)C | 1964.6 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,2TMS,isomer #2 | C[Si](C)(C)OC(=O)C[C@@H](CCCCCCC(=O)O)O[Si](C)(C)C | 1962.7 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,2TMS,isomer #3 | C[Si](C)(C)OC(=O)CCCCCC[C@@H](O)CC(=O)O[Si](C)(C)C | 2012.8 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CCCCCC[C@H](CC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2071.0 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@H](CCCCCCC(=O)O)CC(=O)O | 2161.2 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CCCCCC[C@@H](O)CC(=O)O | 2177.8 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)C[C@H](O)CCCCCCC(=O)O | 2172.4 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCCCC[C@H](CC(=O)O)O[Si](C)(C)C(C)(C)C | 2473.2 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C[C@@H](CCCCCCC(=O)O)O[Si](C)(C)C(C)(C)C | 2441.4 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)CCCCCC[C@@H](O)CC(=O)O[Si](C)(C)C(C)(C)C | 2479.4 | Semi standard non polar | 33892256 | | 3-Hydroxysebacic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCCCCC[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2744.0 | Semi standard non polar | 33892256 |
|
|---|
| General References | - Boulat O, Gradwohl M, Matos V, Guignard JP, Bachmann C: Organic acids in the second morning urine in a healthy Swiss paediatric population. Clin Chem Lab Med. 2003 Dec;41(12):1642-58. [PubMed:14708889 ]
- Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6. [PubMed:8087979 ]
- Muth A, Jung J, Bilke S, Scharrer A, Mosandl A, Sewell AC, Bohles H: Simultaneous enantioselective analysis of chiral urinary metabolites in patients with Zellweger syndrome. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 25;792(2):269-77. [PubMed:12860034 ]
- Bergoffen J, Kaplan P, Hale DE, Bennett MJ, Berry GT: Marked elevation of urinary 3-hydroxydecanedioic acid in a malnourished infant with glycogen storage disease, mimicking long-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 1993;16(5):851-6. [PubMed:8295400 ]
- Greter J, Lindstedt S, Seeman H, Steen G: 3-hydroxydecanedioic acid and related homologues: urinary metabolites in ketoacidosis. Clin Chem. 1980 Feb;26(2):261-5. [PubMed:7353273 ]
|
|---|